Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Clarifies Status of RF Ablation of Lung Tumors - Medical Product Outsourcing

FDA Clarifies Status of RF Ablation of Lung Tumors

Agency clarifies December 2007 health notification on use of RF ablation devices

The FDA has issued a clarification of a public health notification it sent in December 2007 following the reports of death and serious injuries associated with the use of radio-frequency (RF) ablation devices in the treatment of lung tumors.

In the clarification, the agency says it has not cleared any RF ablation devices for the specific treatment indication of partial or complete ablation of lung tumors. However, based on bench-testing data or animal testing, it has cleared such devices for the general indication of soft tissue cutting, coagulation and ablation by thermal coagulation necrosis.

“Under this general indication, RF ablation can be used as a tool to ablate tumors, including lung tumors,” the FDA said.

SOURCE: FDANEWS

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics